 | • レポートコード：QYR2104Z1706 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、サイトメガロウイルス（CMV）網膜炎治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（カプセル、溶液、インプラント、錠剤）、用途別市場規模（病院、外来手術センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・サイトメガロウイルス（CMV）網膜炎治療の市場動向 ・企業の競争状況、市場シェア ・サイトメガロウイルス（CMV）網膜炎治療の種類別市場規模（カプセル、溶液、インプラント、錠剤） ・サイトメガロウイルス（CMV）網膜炎治療の用途別市場規模（病院、外来手術センター、その他） ・サイトメガロウイルス（CMV）網膜炎治療の北米市場規模2016-2027（アメリカ、カナダ） ・サイトメガロウイルス（CMV）網膜炎治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・サイトメガロウイルス（CMV）網膜炎治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・サイトメガロウイルス（CMV）網膜炎治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・サイトメガロウイルス（CMV）網膜炎治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Roche、Gilead Sciences、Takeda、Auritec、Chimerix、Isis、PSivida、Sanofi） ・結論 |
Ophthalmology is the branch of medical science that deals with the management and study of anatomy, physiology, and diseases related to the human eye. Globally, the incidence of eye disorders and vision loss are becoming major public health issues. Some of the major eye diseases include age-related macular degeneration, glaucoma, cataract, bulging eyes, diabetic macular edema, ocular hypertension, retinal detachment, uveitis, and refractive errors. Cytomegalovirus retinitis refers to an eye disease caused by inflammation of the retina of eye. Cytomegalovirus is the causative agent of this disease. It is a herpes virus that attacks the photosensitive cells of retina. This disease spreads from one eye to another. Some common symptoms involved with cytomegalovirus retinitis are blurred vision, photophobia, blind spots and seeing floaters. If left untreated, cytomegalovirus retinitis leads to blindness. Cytomegalovirus generally stays in humans, however it stays dormant. It generally affects people with weak immune system such as HIV-positive patients. Medication for cytomegalovirus retinitis is available in various forms such as capsules, solutions, implants and tablets. The global market for cytomegalovirus retinitis treatment is increasing at a significant rate due to increase in the incidence of cytomegalovirus retinitis cases and growing awareness for different types of eye diseases.
Some of the other major factors driving the global cytomegalovirus retinitis treatment market are increasing prevalence of cytomegalovirus retinitis cases and improvement in the healthcare facilities. In addition, rising government initiatives towards healthcare infrastructure in developing countries are also fueling the growth of global cytomegalovirus retinitis treatment market. However, lack of awareness among people for different types of eye diseases and lack of healthcare insurance are some of the major factors restraining the global cytomegalovirus retinitis treatment market. In addition, rising healthcare cost in developing countries, such as India and China, is hampering affordability of healthcare facilities among the aging population. Majority of the population does not have access to primary healthcare services, attributable to poverty and absence of health insurance.
Market Analysis and Insights: Global Cytomegalovirus Retinitis Treatment Market
The global Cytomegalovirus Retinitis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cytomegalovirus Retinitis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cytomegalovirus Retinitis Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cytomegalovirus Retinitis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cytomegalovirus Retinitis Treatment market.
Global Cytomegalovirus Retinitis Treatment Scope and Market Size
Cytomegalovirus Retinitis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cytomegalovirus Retinitis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Capsules
Solutions
Implants
Tablets
Segment by Application
Hospitals
Ambulatory Surgical Centers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Roche
Gilead Sciences
Takeda
Auritec
Chimerix
Isis
PSivida
Sanofi
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cytomegalovirus Retinitis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Capsules
1.2.3 Solutions
1.2.4 Implants
1.2.5 Tablets
1.3 Market by Application
1.3.1 Global Cytomegalovirus Retinitis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cytomegalovirus Retinitis Treatment Market Perspective (2016-2027)
2.2 Cytomegalovirus Retinitis Treatment Growth Trends by Regions
2.2.1 Cytomegalovirus Retinitis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cytomegalovirus Retinitis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Cytomegalovirus Retinitis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Cytomegalovirus Retinitis Treatment Industry Dynamic
2.3.1 Cytomegalovirus Retinitis Treatment Market Trends
2.3.2 Cytomegalovirus Retinitis Treatment Market Drivers
2.3.3 Cytomegalovirus Retinitis Treatment Market Challenges
2.3.4 Cytomegalovirus Retinitis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cytomegalovirus Retinitis Treatment Players by Revenue
3.1.1 Global Top Cytomegalovirus Retinitis Treatment Players by Revenue (2016-2021)
3.1.2 Global Cytomegalovirus Retinitis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Cytomegalovirus Retinitis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cytomegalovirus Retinitis Treatment Revenue
3.4 Global Cytomegalovirus Retinitis Treatment Market Concentration Ratio
3.4.1 Global Cytomegalovirus Retinitis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cytomegalovirus Retinitis Treatment Revenue in 2020
3.5 Cytomegalovirus Retinitis Treatment Key Players Head office and Area Served
3.6 Key Players Cytomegalovirus Retinitis Treatment Product Solution and Service
3.7 Date of Enter into Cytomegalovirus Retinitis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cytomegalovirus Retinitis Treatment Breakdown Data by Type
4.1 Global Cytomegalovirus Retinitis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Cytomegalovirus Retinitis Treatment Forecasted Market Size by Type (2022-2027)
5 Cytomegalovirus Retinitis Treatment Breakdown Data by Application
5.1 Global Cytomegalovirus Retinitis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Cytomegalovirus Retinitis Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Cytomegalovirus Retinitis Treatment Market Size (2016-2027)
6.2 North America Cytomegalovirus Retinitis Treatment Market Size by Type
6.2.1 North America Cytomegalovirus Retinitis Treatment Market Size by Type (2016-2021)
6.2.2 North America Cytomegalovirus Retinitis Treatment Market Size by Type (2022-2027)
6.2.3 North America Cytomegalovirus Retinitis Treatment Market Size by Type (2016-2027)
6.3 North America Cytomegalovirus Retinitis Treatment Market Size by Application
6.3.1 North America Cytomegalovirus Retinitis Treatment Market Size by Application (2016-2021)
6.3.2 North America Cytomegalovirus Retinitis Treatment Market Size by Application (2022-2027)
6.3.3 North America Cytomegalovirus Retinitis Treatment Market Size by Application (2016-2027)
6.4 North America Cytomegalovirus Retinitis Treatment Market Size by Country
6.4.1 North America Cytomegalovirus Retinitis Treatment Market Size by Country (2016-2021)
6.4.2 North America Cytomegalovirus Retinitis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Cytomegalovirus Retinitis Treatment Market Size (2016-2027)
7.2 Europe Cytomegalovirus Retinitis Treatment Market Size by Type
7.2.1 Europe Cytomegalovirus Retinitis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Cytomegalovirus Retinitis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Cytomegalovirus Retinitis Treatment Market Size by Type (2016-2027)
7.3 Europe Cytomegalovirus Retinitis Treatment Market Size by Application
7.3.1 Europe Cytomegalovirus Retinitis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Cytomegalovirus Retinitis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Cytomegalovirus Retinitis Treatment Market Size by Application (2016-2027)
7.4 Europe Cytomegalovirus Retinitis Treatment Market Size by Country
7.4.1 Europe Cytomegalovirus Retinitis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Cytomegalovirus Retinitis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Cytomegalovirus Retinitis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Cytomegalovirus Retinitis Treatment Market Size by Type
8.2.1 Asia-Pacific Cytomegalovirus Retinitis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cytomegalovirus Retinitis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cytomegalovirus Retinitis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Cytomegalovirus Retinitis Treatment Market Size by Application
8.3.1 Asia-Pacific Cytomegalovirus Retinitis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cytomegalovirus Retinitis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cytomegalovirus Retinitis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Cytomegalovirus Retinitis Treatment Market Size by Region
8.4.1 Asia-Pacific Cytomegalovirus Retinitis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cytomegalovirus Retinitis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cytomegalovirus Retinitis Treatment Market Size (2016-2027)
9.2 Latin America Cytomegalovirus Retinitis Treatment Market Size by Type
9.2.1 Latin America Cytomegalovirus Retinitis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Cytomegalovirus Retinitis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Cytomegalovirus Retinitis Treatment Market Size by Type (2016-2027)
9.3 Latin America Cytomegalovirus Retinitis Treatment Market Size by Application
9.3.1 Latin America Cytomegalovirus Retinitis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Cytomegalovirus Retinitis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Cytomegalovirus Retinitis Treatment Market Size by Application (2016-2027)
9.4 Latin America Cytomegalovirus Retinitis Treatment Market Size by Country
9.4.1 Latin America Cytomegalovirus Retinitis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Cytomegalovirus Retinitis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cytomegalovirus Retinitis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Cytomegalovirus Retinitis Treatment Market Size by Type
10.2.1 Middle East & Africa Cytomegalovirus Retinitis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cytomegalovirus Retinitis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cytomegalovirus Retinitis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Cytomegalovirus Retinitis Treatment Market Size by Application
10.3.1 Middle East & Africa Cytomegalovirus Retinitis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cytomegalovirus Retinitis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cytomegalovirus Retinitis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Cytomegalovirus Retinitis Treatment Market Size by Country
10.4.1 Middle East & Africa Cytomegalovirus Retinitis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cytomegalovirus Retinitis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Cytomegalovirus Retinitis Treatment Introduction
11.1.4 Roche Revenue in Cytomegalovirus Retinitis Treatment Business (2016-2021)
11.1.5 Roche Recent Development
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Details
11.2.2 Gilead Sciences Business Overview
11.2.3 Gilead Sciences Cytomegalovirus Retinitis Treatment Introduction
11.2.4 Gilead Sciences Revenue in Cytomegalovirus Retinitis Treatment Business (2016-2021)
11.2.5 Gilead Sciences Recent Development
11.3 Takeda
11.3.1 Takeda Company Details
11.3.2 Takeda Business Overview
11.3.3 Takeda Cytomegalovirus Retinitis Treatment Introduction
11.3.4 Takeda Revenue in Cytomegalovirus Retinitis Treatment Business (2016-2021)
11.3.5 Takeda Recent Development
11.4 Auritec
11.4.1 Auritec Company Details
11.4.2 Auritec Business Overview
11.4.3 Auritec Cytomegalovirus Retinitis Treatment Introduction
11.4.4 Auritec Revenue in Cytomegalovirus Retinitis Treatment Business (2016-2021)
11.4.5 Auritec Recent Development
11.5 Chimerix
11.5.1 Chimerix Company Details
11.5.2 Chimerix Business Overview
11.5.3 Chimerix Cytomegalovirus Retinitis Treatment Introduction
11.5.4 Chimerix Revenue in Cytomegalovirus Retinitis Treatment Business (2016-2021)
11.5.5 Chimerix Recent Development
11.6 Isis
11.6.1 Isis Company Details
11.6.2 Isis Business Overview
11.6.3 Isis Cytomegalovirus Retinitis Treatment Introduction
11.6.4 Isis Revenue in Cytomegalovirus Retinitis Treatment Business (2016-2021)
11.6.5 Isis Recent Development
11.7 PSivida
11.7.1 PSivida Company Details
11.7.2 PSivida Business Overview
11.7.3 PSivida Cytomegalovirus Retinitis Treatment Introduction
11.7.4 PSivida Revenue in Cytomegalovirus Retinitis Treatment Business (2016-2021)
11.7.5 PSivida Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Cytomegalovirus Retinitis Treatment Introduction
11.8.4 Sanofi Revenue in Cytomegalovirus Retinitis Treatment Business (2016-2021)
11.8.5 Sanofi Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Cytomegalovirus Retinitis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Capsules
Table 3. Key Players of Solutions
Table 4. Key Players of Implants
Table 5. Key Players of Tablets
Table 6. Global Cytomegalovirus Retinitis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Cytomegalovirus Retinitis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Cytomegalovirus Retinitis Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Cytomegalovirus Retinitis Treatment Market Share by Regions (2016-2021)
Table 10. Global Cytomegalovirus Retinitis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Cytomegalovirus Retinitis Treatment Market Share by Regions (2022-2027)
Table 12. Cytomegalovirus Retinitis Treatment Market Trends
Table 13. Cytomegalovirus Retinitis Treatment Market Drivers
Table 14. Cytomegalovirus Retinitis Treatment Market Challenges
Table 15. Cytomegalovirus Retinitis Treatment Market Restraints
Table 16. Global Cytomegalovirus Retinitis Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Cytomegalovirus Retinitis Treatment Market Share by Players (2016-2021)
Table 18. Global Top Cytomegalovirus Retinitis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cytomegalovirus Retinitis Treatment as of 2020)
Table 19. Ranking of Global Top Cytomegalovirus Retinitis Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Cytomegalovirus Retinitis Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Cytomegalovirus Retinitis Treatment Product Solution and Service
Table 23. Date of Enter into Cytomegalovirus Retinitis Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Cytomegalovirus Retinitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Cytomegalovirus Retinitis Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Cytomegalovirus Retinitis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Cytomegalovirus Retinitis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Cytomegalovirus Retinitis Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Cytomegalovirus Retinitis Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Cytomegalovirus Retinitis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Cytomegalovirus Retinitis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Cytomegalovirus Retinitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Cytomegalovirus Retinitis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Cytomegalovirus Retinitis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Cytomegalovirus Retinitis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Cytomegalovirus Retinitis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Cytomegalovirus Retinitis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Cytomegalovirus Retinitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Cytomegalovirus Retinitis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Cytomegalovirus Retinitis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Cytomegalovirus Retinitis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Cytomegalovirus Retinitis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Cytomegalovirus Retinitis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Cytomegalovirus Retinitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Cytomegalovirus Retinitis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Cytomegalovirus Retinitis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Cytomegalovirus Retinitis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Cytomegalovirus Retinitis Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Cytomegalovirus Retinitis Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Cytomegalovirus Retinitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Cytomegalovirus Retinitis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Cytomegalovirus Retinitis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Cytomegalovirus Retinitis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Cytomegalovirus Retinitis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Cytomegalovirus Retinitis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Cytomegalovirus Retinitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Cytomegalovirus Retinitis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Cytomegalovirus Retinitis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Cytomegalovirus Retinitis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Cytomegalovirus Retinitis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Cytomegalovirus Retinitis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Roche Company Details
Table 64. Roche Business Overview
Table 65. Roche Cytomegalovirus Retinitis Treatment Product
Table 66. Roche Revenue in Cytomegalovirus Retinitis Treatment Business (2016-2021) & (US$ Million)
Table 67. Roche Recent Development
Table 68. Gilead Sciences Company Details
Table 69. Gilead Sciences Business Overview
Table 70. Gilead Sciences Cytomegalovirus Retinitis Treatment Product
Table 71. Gilead Sciences Revenue in Cytomegalovirus Retinitis Treatment Business (2016-2021) & (US$ Million)
Table 72. Gilead Sciences Recent Development
Table 73. Takeda Company Details
Table 74. Takeda Business Overview
Table 75. Takeda Cytomegalovirus Retinitis Treatment Product
Table 76. Takeda Revenue in Cytomegalovirus Retinitis Treatment Business (2016-2021) & (US$ Million)
Table 77. Takeda Recent Development
Table 78. Auritec Company Details
Table 79. Auritec Business Overview
Table 80. Auritec Cytomegalovirus Retinitis Treatment Product
Table 81. Auritec Revenue in Cytomegalovirus Retinitis Treatment Business (2016-2021) & (US$ Million)
Table 82. Auritec Recent Development
Table 83. Chimerix Company Details
Table 84. Chimerix Business Overview
Table 85. Chimerix Cytomegalovirus Retinitis Treatment Product
Table 86. Chimerix Revenue in Cytomegalovirus Retinitis Treatment Business (2016-2021) & (US$ Million)
Table 87. Chimerix Recent Development
Table 88. Isis Company Details
Table 89. Isis Business Overview
Table 90. Isis Cytomegalovirus Retinitis Treatment Product
Table 91. Isis Revenue in Cytomegalovirus Retinitis Treatment Business (2016-2021) & (US$ Million)
Table 92. Isis Recent Development
Table 93. PSivida Company Details
Table 94. PSivida Business Overview
Table 95. PSivida Cytomegalovirus Retinitis Treatment Product
Table 96. PSivida Revenue in Cytomegalovirus Retinitis Treatment Business (2016-2021) & (US$ Million)
Table 97. PSivida Recent Development
Table 98. Sanofi Company Details
Table 99. Sanofi Business Overview
Table 100. Sanofi Revenue in Cytomegalovirus Retinitis Treatment Business (2016-2021) & (US$ Million)
Table 101. Sanofi Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cytomegalovirus Retinitis Treatment Market Share by Type: 2020 VS 2027
Figure 2. Capsules Features
Figure 3. Solutions Features
Figure 4. Implants Features
Figure 5. Tablets Features
Figure 6. Global Cytomegalovirus Retinitis Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Ambulatory Surgical Centers Case Studies
Figure 9. Others Case Studies
Figure 10. Cytomegalovirus Retinitis Treatment Report Years Considered
Figure 11. Global Cytomegalovirus Retinitis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Cytomegalovirus Retinitis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Cytomegalovirus Retinitis Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Cytomegalovirus Retinitis Treatment Market Share by Regions (2022-2027)
Figure 15. Global Cytomegalovirus Retinitis Treatment Market Share by Players in 2020
Figure 16. Global Top Cytomegalovirus Retinitis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cytomegalovirus Retinitis Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Cytomegalovirus Retinitis Treatment Revenue in 2020
Figure 18. Global Cytomegalovirus Retinitis Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Cytomegalovirus Retinitis Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Cytomegalovirus Retinitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Cytomegalovirus Retinitis Treatment Market Share by Type (2016-2027)
Figure 22. North America Cytomegalovirus Retinitis Treatment Market Share by Application (2016-2027)
Figure 23. North America Cytomegalovirus Retinitis Treatment Market Share by Country (2016-2027)
Figure 24. United States Cytomegalovirus Retinitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Cytomegalovirus Retinitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Cytomegalovirus Retinitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Cytomegalovirus Retinitis Treatment Market Share by Type (2016-2027)
Figure 28. Europe Cytomegalovirus Retinitis Treatment Market Share by Application (2016-2027)
Figure 29. Europe Cytomegalovirus Retinitis Treatment Market Share by Country (2016-2027)
Figure 30. Germany Cytomegalovirus Retinitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Cytomegalovirus Retinitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Cytomegalovirus Retinitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Cytomegalovirus Retinitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Cytomegalovirus Retinitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Cytomegalovirus Retinitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Cytomegalovirus Retinitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Cytomegalovirus Retinitis Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Cytomegalovirus Retinitis Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Cytomegalovirus Retinitis Treatment Market Share by Region (2016-2027)
Figure 40. China Cytomegalovirus Retinitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Cytomegalovirus Retinitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Cytomegalovirus Retinitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Cytomegalovirus Retinitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Cytomegalovirus Retinitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Cytomegalovirus Retinitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Cytomegalovirus Retinitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Cytomegalovirus Retinitis Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Cytomegalovirus Retinitis Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Cytomegalovirus Retinitis Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Cytomegalovirus Retinitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Cytomegalovirus Retinitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Cytomegalovirus Retinitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Cytomegalovirus Retinitis Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Cytomegalovirus Retinitis Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Cytomegalovirus Retinitis Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Cytomegalovirus Retinitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Cytomegalovirus Retinitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Cytomegalovirus Retinitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Roche Revenue Growth Rate in Cytomegalovirus Retinitis Treatment Business (2016-2021)
Figure 60. Gilead Sciences Revenue Growth Rate in Cytomegalovirus Retinitis Treatment Business (2016-2021)
Figure 61. Takeda Revenue Growth Rate in Cytomegalovirus Retinitis Treatment Business (2016-2021)
Figure 62. Auritec Revenue Growth Rate in Cytomegalovirus Retinitis Treatment Business (2016-2021)
Figure 63. Chimerix Revenue Growth Rate in Cytomegalovirus Retinitis Treatment Business (2016-2021)
Figure 64. Isis Revenue Growth Rate in Cytomegalovirus Retinitis Treatment Business (2016-2021)
Figure 65. PSivida Revenue Growth Rate in Cytomegalovirus Retinitis Treatment Business (2016-2021)
Figure 66. Sanofi Revenue Growth Rate in Cytomegalovirus Retinitis Treatment Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
世界の網膜色素変性症治療＆管理市場規模・現状・予測（2021年-2027年） Retinitis pigmentosa (RP) is a genetic disorder of the eyes that causes loss of vision. Retinitis pigmentosa is generally inherited from a person's parents. Mutations in one of more than 50 genes is involved. Market Analysis and Insights: Global Retinitis Pigmentosa Treatment & Management Market The…- 世界のサイトメガロウイルス（CMV）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cytomegalovirus Therapeutics Market The global Cytomegalovirus Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integri…
- 世界のサイトメガロウイルス（CMV）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cytomegalovirus Therapeutics Market The global Cytomegalovirus Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integri…
- 世界の網膜色素変性症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Retinitis Pigmentosa Treatment Market The global Retinitis Pigmentosa Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data int…
- 世界のサイトメガロウイルス（CMV）感染市場規模・現状・予測（2021年-2027年） Cytomegalovirus (CMV) infection is one of the common herpesvirus infection with different symptoms, which occurs in people of all ages across the globe. This viral infection is communicable and can easily spread through body fluids such as blood, urine, saliva, semen and breast milk. The infection c…